Unexpected response to cisplatin rechallenge after immune checkpoint inhibitors in patients with metastatic urothelial carcinoma refractory to platinum regimen
- PMID: 30316610
- DOI: 10.1016/j.ejca.2018.09.002
Unexpected response to cisplatin rechallenge after immune checkpoint inhibitors in patients with metastatic urothelial carcinoma refractory to platinum regimen
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
